TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
批准号:
2856413
负责人:
SHU-WING NG
金额:
$11.87万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-15 至 2001-12-31
关键词:
CHO cells DNA gyrase antineoplastics binding proteins complementary DNA drug resistance gel mobility shift assay gene expression genetic promoter element genetic regulation genetic transcription isozymes messenger RNA neoplasm /cancer chemotherapy nuclear runoff assay tissue /cell culture transfection
中文摘要
II型DNA拓扑异构酶(TopII)是一种必需的酶,也是
临床上最有效的细胞内靶点数目
抗肿瘤药物。TOP II的细胞内水平是一种重要的
细胞对TOP II靶向敏感性的决定因素
药物和TOP II表达减少是最常观察到的TOP
II-介导的耐药性。在两个顶级II亚型中,170 kD
形式(Top IIpha)是调节top II功能的主要形式
并且对顶级II靶向制剂高度敏感。转染法和
通过负反馈机制过表达top IIpha基因,
对于严格调节细胞顶级IIAlpha水平很重要
也可能有助于减少药物中Top IIpha的表达
抵抗。此外,一个顺式元件及其各自的结合
在中国仓鼠TOP IIAlpha启动子和
它与c-erbB2中的一种新的抑制元件相似。
推动者。TOPⅡα和c-erbB2基因的扩增和过表达
基因与乳腺癌预后不良有关。因此,
对TOP IIAlpha调控机制的研究已经
显著的生物学和临床相关性。
在这一建议中,控制自动调节的分子机制
过表达CHO的EMT6细胞内源性TOP IIpha的表达
两种药物耐药患者的Top IIpha及其表达降低
将对中国仓鼠细胞系进行调查和比较。这个
然后,结果将用于调制TOP IIAlpha的研究
耐药细胞株中的表达及其对药物的敏感性
将对细胞进行化验。基于CHO与人类的高度同源性
到IIpha启动子和保守的调控元件及结合
因素,本研究的结果对TOP II的研究是相关的
在人类癌症中的表达及其克服策略的发展
TOP II介导的肿瘤化疗耐药。澄清
调节TIP Iipha表达的机制也是重要的
研究TOP II在不同细胞功能中的作用。
英文摘要
Type II DNA topoisomerase (topII) is an essential enzyme and is also the
intracellular target for the number of clinically most effective
antineoplastic agents. The intracellular level of top II is an import
determining factor for the cellular sensitivity to top II-targeting
drugs and reduced top II expression is the most commonly observed top
II-mediated drug resistance. Of the two top II isoforms, the 170 kD
form (top IIalpha) is the predominant form to mediate top II functions
and is highly sensitive to top II-targeting agents. Transfection and
overexpression of top IIalpha gene by negative feedback mechanism, which
is important for a strict regulation of the cellular top IIalpha level
and may also contribute to reduced top IIalpha expression in drug
resistance. In addition, one cis-element and its respective binding
activity was identified in the Chinese hamster top IIalpha promoter and
it bears resemblance to a novel inhibitory element in the c-erbB2
promoter. Amplification and overexpression of top IIalpha and c-erbB2
genes have been associated with poor prognosis in breast cancer. Hence,
the study of mechanisms by which top IIalpha is regulated has
significant biological and clinical relevance.
In this proposal, the molecular mechanisms governing the autoregulation
of endogenous top IIalpha expression in EMT6 cells that overexpress CHO
top IIalpha and the reduced top IIalpha expression in two drug resistant
Chinese hamster cell lines will be investigated and compared. The
results will then be used in the study of modulating the top IIalpha
expression in the resistant cell lines and the drug sensitivity of the
cells will be assayed. Based on the high homology between CHO and human
to IIalpha promoters and the conserved regulatory elements and binding
factors, the results of this study are relevant for the study of top II
expression in human cancer and for developing strategies in overcoming
top II-mediated drug resistance in cancer chemotherapy. Elucidating the
mechanisms of regulating tip Iialpha expression is also important in
studying the roles of top II in different cell functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting lipid metabolic and signaling enzyme in ovarian cancer
-
批准号:7873528
-
项目类别:
-
资助金额:$21.79万
-
财政年份:2010
-
负责人:SHU-WING NG
-
依托单位:
Targeting lipid metabolic and signaling enzyme in ovarian cancer
-
批准号:8049249
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2010
-
负责人:SHU-WING NG
-
依托单位:
XIST RNA and Ovarian Cancer
-
批准号:6874973
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2004
-
负责人:SHU-WING NG
-
依托单位:
XIST RNA and Ovarian Cancer
-
批准号:6712604
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2004
-
负责人:SHU-WING NG
-
依托单位:
Biomarkers for Ovarian Cancer
-
批准号:6622897
-
项目类别:
-
资助金额:$17.3万
-
财政年份:2002
-
负责人:SHU-WING NG
-
依托单位:
Biomarkers for Ovarian Cancer
-
批准号:6458955
-
项目类别:
-
资助金额:$16.83万
-
财政年份:2002
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6386613
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6130864
-
项目类别:
-
资助金额:$28.15万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6520086
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6636344
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2009539
-
项目类别:
-
资助金额:$5.57万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2633924
-
项目类别:
-
资助金额:$6.21万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2739730
-
项目类别:
-
资助金额:$11.87万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:6137566
-
项目类别:
-
资助金额:$11.87万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:6342005
-
项目类别:
-
资助金额:$11.87万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
海外基金